(Total Views: 384)
Posted On: 01/17/2020 10:59:53 AM
Post# of 149116
Like you, I expect once they prove MOA in CCR5 cancers and get approval for TNBC (AA IMO), off-label prescriptions will be huge!
The question is who will be commercializing and/or distributing leronlimab for cancer? Contracted out with Syneos Health or similar company, license deal, ????
The question is who will be commercializing and/or distributing leronlimab for cancer? Contracted out with Syneos Health or similar company, license deal, ????
(0)
(0)
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
Scroll down for more posts ▼
